Minutes of the CVMP meeting 4-6 November 2025

Work plan for the Committee for Veterinary Medicinal Products (CVMP) Antimicrobials Working Party (AWP) 2026

CTIS Simplification Task Force: topics for analysis

Clinical Trials Information System (CTIS) sponsor end user training programme - March 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 9 March 2026, 09:00 (CET) to 12 March 2026, 13:30 (CET)

Biomarkers in oncology indications approved in the EU: key facts

15th Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 December 2025, 09:00 (CET) to 11 December 2025, 10:00 (CET)

EMA multistakeholder workshop on supporting innovation in cardiovascular medicines and medical devices in the EU, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 1 July 2026 to 2 July 2026

Human medicines European public assessment report (EPAR): Clopidogrel Viatris (previously Clopidogrel Taw Pharma), clopidogrel, Date of authorisation: 16/10/2009, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Synagis, palivizumab, Date of authorisation: 13/08/1999, Revision: 46, Status: Authorised

Human medicines European public assessment report (EPAR): Azacitidine Mylan, azacitidine, Date of authorisation: 27/03/2020, Revision: 11, Status: Authorised